ROS induced by therapeutic agent contributes to the formation of the intramolecular disulfide bond of Akt and the increase of the phosphorylation level of Akt, which results in the activation of Snail, mTOR, and ERK, and the induction of EMT and drug resistance of cancer cells [23, 33–35]. The gene discussed is SNAI1; the disease is cancer.